Tech Company Financing Transactions

Earli Funding Round

Khosla Ventures, Andreessen Horowitz and Casdin Capital participated in a $40 million Series A funding round for Earli. The round was recorded on 1/13/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare IT

Mailing Address

161 Oyster Point Blvd. 201
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.earli.com

Email Address

[email protected]

Overview

Earli is a biotechnology company focused on making cancer that is detected early, localizable and therefore treatable, via its novel "Synthetic Biopsies." By forcing cancer cells to produce synthetic biomarkers that do not belong in the human body, they are made highly detectable and localizable in a PET scanner, so they can be treated at early stages, when survival rates are multiple times higher.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Cyriac Roeding

        

Chief Scientific Officer

David Suhy

        

Browse more venture capital transactions:

Prev: 1/13/2021: Neat Capital venture capital transaction
Next: 1/13/2021: Opticyte venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary